In agreement, population-based studies have shown that during chronic inflammatory diseases such as periodontitis, pulmonary tuberculosis, and cystic fibrosis, hypomethylation of the TLR2 promoter leads to enhanced expression of TLR233,34,46. The gene discussed is TLR2; the disease is cystic fibrosis.